• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗精神疾病的药物对口腔健康的影响。

Oral health impacts of medications used to treat mental illness.

作者信息

Cockburn N, Pradhan A, Taing M W, Kisely S, Ford P J

机构信息

The University of Queensland, School of Dentistry, UQ Oral Health Centre, Herston, Brisbane 4006 QLD, Australia.

The University of Queensland, School of Dentistry, UQ Oral Health Centre, Herston, Brisbane 4006 QLD, Australia.

出版信息

J Affect Disord. 2017 Dec 1;223:184-193. doi: 10.1016/j.jad.2017.07.037. Epub 2017 Jul 23.

DOI:10.1016/j.jad.2017.07.037
PMID:28759866
Abstract

BACKGROUND

Many psychotropic medications affect oral health. This review identified oral side effects for antidepressant, antipsychotic, anticonvulsant, antianxiety and sedative drugs that are recommended in Australia for the management of common mental illnesses and provides recommendations to manage these side-effects.

METHODS

The Australian Therapeutic Guidelines and the Australian Medicines Handbook were searched for medications used to treat common mental health conditions. For each medication, the generic name, class, and drug company reported side-effects were extracted from the online Monthly Index of Medical Specialties (eMIMs) and UpToDate databases. Meyler's Side Effect of Drugs Encyclopaedia was used to identify additional oral adverse reactions to these medications.

RESULTS

Fifty-seven drugs were identified: 23 antidepressants, 22 antipsychotics or mood stabilisers, and 12 anxiolytic or sedative medications. Xerostomia (91%) the most commonly reported side effect among all classes of medications of the 28 identified symptoms. Other commonly reported adverse effects included dysguesia (65%) for antidepressants, and tardive dyskinesia (94%) or increased salivation (78%) for antipsychotic medications.

CONCLUSIONS

While xerostomia has often been reported as a common adverse effect of psychotropic drugs, this review has identified additional side effects including dysguesia from antidepressants and tardive dyskinesia and increased salivation from antipsychotics. Clinicians should consider oral consequences of psychotropic medication in addition to other side-effects when prescribing. For antidepressants, this would mean choosing duloxetine, agomelatine and any of the serotonin re-uptake inhibitors except sertraline. In the case of antipsychotics and mood stabilisers, atypical agents have less oral side effects than older alternatives.

摘要

背景

许多精神药物会影响口腔健康。本综述确定了澳大利亚推荐用于治疗常见精神疾病的抗抑郁药、抗精神病药、抗惊厥药、抗焦虑药和镇静药的口腔副作用,并提供了管理这些副作用的建议。

方法

检索澳大利亚治疗指南和澳大利亚药品手册中用于治疗常见精神健康状况的药物。对于每种药物,从在线医学专业月度索引(eMIMs)和UpToDate数据库中提取通用名、类别和药品公司报告的副作用。使用《梅耶尔药物副作用百科全书》来确定这些药物的其他口腔不良反应。

结果

共识别出57种药物:23种抗抑郁药、22种抗精神病药或情绪稳定剂以及12种抗焦虑或镇静药物。在确定的28种症状中,口干(91%)是所有药物类别中最常报告的副作用。其他常见的不良反应包括抗抑郁药引起的味觉障碍(65%),以及抗精神病药物引起的迟发性运动障碍(94%)或流涎增加(78%)。

结论

虽然口干常被报告为精神药物的常见不良反应,但本综述确定了其他副作用,包括抗抑郁药引起的味觉障碍、迟发性运动障碍以及抗精神病药引起的流涎增加。临床医生在开处方时,除了考虑其他副作用外,还应考虑精神药物对口腔的影响。对于抗抑郁药,这意味着选择度洛西汀、阿戈美拉汀以及除舍曲林之外的任何一种5-羟色胺再摄取抑制剂。对于抗精神病药和情绪稳定剂,非典型药物的口腔副作用比旧的替代药物少。

相似文献

1
Oral health impacts of medications used to treat mental illness.用于治疗精神疾病的药物对口腔健康的影响。
J Affect Disord. 2017 Dec 1;223:184-193. doi: 10.1016/j.jad.2017.07.037. Epub 2017 Jul 23.
2
Managing the oral side-effects of medications used to treat multiple sclerosis.应对用于治疗多发性硬化症的药物的口腔副作用。
Aust Dent J. 2017 Sep;62(3):331-336. doi: 10.1111/adj.12510. Epub 2017 May 31.
3
Using antipsychotic agents in older patients.在老年患者中使用抗精神病药物。
J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4.
4
Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.患有精神疾病的老年人使用精神药物,特别是抗精神病药物:对不同诊断组耐受性和使用情况的系统研究
Int J Geriatr Psychiatry. 2005 Sep;20(9):842-7. doi: 10.1002/gps.1365.
5
Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study.澳大利亚社区严重和持续性精神疾病患者的精神药物使用情况:一项横断面研究。
BMC Psychiatry. 2022 Nov 15;22(1):705. doi: 10.1186/s12888-022-04324-0.
6
Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011.2000 年至 2011 年澳大利亚精神药物使用趋势。
Aust N Z J Psychiatry. 2013 Jan;47(1):74-87. doi: 10.1177/0004867412466595. Epub 2012 Nov 9.
7
[Psychotropic drugs].[精神药物]
Ther Umsch. 1999 Dec;56(12):719-25. doi: 10.1024/0040-5930.56.12.719.
8
Relationship between xerostomia and psychotropic drugs in patients with schizophrenia: evaluation using an oral moisture meter.精神分裂症患者口干与精神药物之间的关系:使用口腔湿度计进行评估
J Clin Pharm Ther. 2016 Dec;41(6):684-688. doi: 10.1111/jcpt.12449. Epub 2016 Sep 24.
9
Prolonged QT Interval in Patients Receiving Psychotropic Medications.接受精神药物治疗患者的QT间期延长
J Am Psychiatr Nurses Assoc. 2020 Jul/Aug;26(4):344-353. doi: 10.1177/1078390319873049. Epub 2019 Sep 11.
10
Psychopharmacology in pregnancy.孕期精神药理学
J Perinat Neonatal Nurs. 2001 Mar;14(4):12-25. doi: 10.1097/00005237-200103000-00003.

引用本文的文献

1
Chlorpromazine induces hyposalivation by inhibiting muscarinic Ca signaling in salivary glands.氯丙嗪通过抑制唾液腺中的毒蕈碱型钙信号传导诱导唾液分泌减少。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 23. doi: 10.1007/s00210-025-04438-8.
2
Oral Health in Individuals with Severe Mental Illness on Second-Generation Antipsychotics-A Scoping Review.使用第二代抗精神病药物的严重精神疾病患者的口腔健康——一项范围综述
J Oral Pathol Med. 2025 Jul;54(6):401-412. doi: 10.1111/jop.13639. Epub 2025 May 6.
3
Oral side effects of fluoxetine in patients with depressive disorder: A systematic review.
氟西汀对抑郁症患者的口腔副作用:一项系统评价。
Med Oral Patol Oral Cir Bucal. 2025 May 1;30(3):e373-e382. doi: 10.4317/medoral.26947.
4
Exploring Oral Health Promotion Among Mental Health Providers: An Integrative Review.探索心理健康服务提供者中的口腔健康促进:一项综合综述。
Int J Ment Health Nurs. 2025 Feb;34(1):e70007. doi: 10.1111/inm.70007.
5
Mental and Oral Health: A Dual Frontier in Healthcare Integration and Prevention.精神与口腔健康:医疗整合与预防的双重前沿
Cureus. 2024 Dec 23;16(12):e76264. doi: 10.7759/cureus.76264. eCollection 2024 Dec.
6
Oral health knowledge, attitudes, and practices of people living with mental illness: a mixed-methods systematic review.口腔健康知识、态度和行为与精神疾病患者:一项混合方法系统评价。
BMC Public Health. 2024 Aug 21;24(1):2263. doi: 10.1186/s12889-024-19713-1.
7
Oral discomfort and health behavior of patients with typical vs. atypical antipsychotic drugs.使用典型与非典型抗精神病药物患者的口腔不适与健康行为
Front Psychiatry. 2024 Jun 26;15:1420010. doi: 10.3389/fpsyt.2024.1420010. eCollection 2024.
8
A Review on Lipid-based Nanoformulations for Targeting Brain through Non-invasive Nasal Route.基于脂质的纳米制剂经非侵入性鼻腔途径靶向脑部的综述
Pharm Nanotechnol. 2025;13(1):143-154. doi: 10.2174/0122117385293436240321090218.
9
The relationship between self-reported poor mental health and complete tooth loss among the US adult population in 2019.2019年美国成年人口中自我报告的心理健康状况不佳与牙齿完全脱落之间的关系。
Front Oral Health. 2024 Mar 28;5:1363982. doi: 10.3389/froh.2024.1363982. eCollection 2024.
10
Oral Health-Related Quality of Life in Adult Patients with Depression or Attention Deficit Hyperactivity Disorder (ADHD).抑郁症或注意力缺陷多动障碍(ADHD)成年患者的口腔健康相关生活质量
J Clin Med. 2023 Nov 20;12(22):7192. doi: 10.3390/jcm12227192.